Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) continues to have a pipeline of drugs that might provide further validation for the company's platform, but recent updates were not a roaring success.

New research has cast doubt on whether today's advanced artificial intelligence models are truly capable of deep reasoning.

This letter proposes a novel random Fourier features (RFF) based sparsity-aware Kernel recursive adaptive filtering algorithm which employs generalized maximum Versoria criterion (GMVC) as an ...

Active Noise Control (ANC) is an effective technique for removing undesirable disturbances based on destructive interference between two noises (i.e., the superposition principle). To reduce the ...

LeetCode is super important for coding interviews because lots of big tech companies use its style of problems. Getting good ...

Using this information, the model can then tell us the probability of a drug-protein interaction that we did not previously ...

AI Oversight and the BBB. What the failed effort to pass a moratorium on AI legislation tells us, and what should states do ...

A research team from the Hefei Institutes of Physical Science of the Chinese Academy of Sciences has proposed a novel model optimization algorithm—External Calibration-Assisted Screening (ECA)— that ...

Objective Long-term azithromycin treatment effectively prevents acute exacerbations of chronic obstructive pulmonary disease ...

Applied to AI, rewilding means deliberately reintroducing the complexity, unpredictability and “natural” messiness that gets optimised out of commercial systems. Metaphorically, it’s creating pathways ...